Loading interface...

Nebicard V Tablet

Manufactured byTorrent Pharmaceuticals Ltd.
ContainsValsartan (80 mg) + Nebivolol (5 mg)
Description

Nebicard V Tablet is a combination medicine used for the treatment of high blood pressure. Patients are advised to maintain a strict exercise and diet regimen along with this medicine for the best possible effect. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Nebicard V Tablet

  • Abdominal or stomach pain
  • Chest pain
  • Decreased urine output
  • Difficulty in breathing
  • Chest tightness
  • Swelling of face, fingers and feet.
  • Weight gain
  • Unusual tiredness or weakness

Uses of Nebicard V Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 to 2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, irregular heart rate, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to valsartan, other angiotensin receptor blockers, nebivolol, or any other beta-blockers.

Aliskiren

Coadministration of aliskiren and this combination medicine is not recommended due to the increased risk of serious adverse effects. This risk is especially higher in the elderly population and in patients with diabetes and kidney diseases.

Severe liver impairment

This medicine is not recommended for use in patients with severe liver impairment due to the increased risk of serious adverse effects.

Heart Failure

This medicine is not recommended for use in patients suffering from a heart failure due to the increased risk of worsening of the patient's condition.

Heart diseases

This medicine is not recommended for use in patients suffering from heart diseases such as a heart block greater than first degree, cardiogenic shock, sick sinus syndrome (without a permanent pacemaker in place), sinus bradycardia, etc. since it may worsen the patient's condition.

Circulatory Disorders

This medicine is not recommended for use in patients suffering from blood circulation disorders since it may worsen the patient's condition.

Lung disease

This medicine is not recommended for use in patients suffering from obstructive lung diseases such as bronchial asthma or bronchospasm since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Hypotension

Symptomatic hypotension may occur in patients with volume depletion or patients who are treated with high doses of diuretics. It is advised to correct the condition before beginning treatment with this medicine.

Hyperkalemia

This medicine may increase the potassium levels in the blood (hyperkalemia). This may cause serious side effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (potassium-sparing diuretics and potassium supplements) during treatment with this medicine.

Impaired liver function

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of serious adverse effects. Close monitoring of liver function is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Pediatric population

This medicine is not recommended for use in children since the safety and efficacy of use are not clinically established.

Major surgery

This medicine should be used with extreme caution in patients undergoing a major surgery due to the increased risk of severe adverse effects. Close monitoring of heart function is recommended for such patients. An appropriate anesthetic agent should be chosen to minimize the interaction as well as side effects.

Heart failure

This medicine should be used with caution in patients suffering from heart diseases due to the increased risk of heart failure. Close monitoring of heart function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Ischemic heart disease

This medicine is not recommended for use in patients with ischemic heart disease unless specified by the doctor. Since the risk of significant adverse effects is high in such patients on abrupt discontinuation of this medicine, your doctor will determine the appropriate course based on your clinical condition.

Lung diseases

This medicine is not recommended for use in patients suffering from obstructive lung diseases such as bronchial asthma, bronchospasm, or Chronic Obstructive Pulmonary Disease since it may worsen the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.

Diabetes

This medicine should be used with caution in patients suffering from diabetes due to the increased risk of very low blood sugar levels. Close monitoring of blood sugar levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Hyperthyroidism

This medicine should be administered with caution in patients suffering from hyperthyroidism since it may mask some of the patient's symptoms. Report any unusual symptoms to the doctor immediately. Close monitoring of thyroid hormone levels is recommended for such patient. Replacement with a suitable alternative may be required based on the clinical condition.

Peripheral vascular diseases

This medicine should be used with caution in patients suffering from peripheral vascular diseases since it may worsen the patient's condition. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required in some cases based on the clinical condition.

Other medicines

This medicine may interact with many other medicines and may cause serious adverse effects. It is advised that you report to the doctor all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Impaired renal function

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of serious adverse effects. Close monitoring of kidney function is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Driving and operating machines

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience these symptoms during treatment with this medicine.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not take extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, irregular heart rate, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Amlodipine

Diltiazem

Fluoxetine

Amiodarone

Aliskiren

Captopril

Insulin

Aminophylline

Ergotamine

Dexamethasone

Nonsteroidal anti-inflammatory medicines

Disease interactions

Angioedema

This medicine is not recommended for use in patients with a history of angioedema or a family history of angioedema due to the increased risk of recurrent symptoms. Report any incidence of swelling of the face, lips, and eyes to the doctor on priority. Replacement with a suitable alternative may be required based on the clinical condition.

Renal impairment

This medicine should be used with extreme caution in patients with renal impairment due to the increased risk of serious adverse effects. Close monitoring of kidney function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Heart Block

This medicine is not recommended for use in patients with a heart block greater than the first degree since it may worsen the patient's condition. Replacement with a suitable alternative should be done under your doctor's supervision.

Diabetes

This medicine should be used with caution in patients suffering from diabetes due to the increased risk of very low blood sugar levels. Close monitoring of blood sugar levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of serious adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Glaucoma

This medicine should be administered with caution in patients suffering from glaucoma. A change in the dose of the current glaucoma medicine may be required in some cases. Replacement with a suitable alternative may be necessary based on the clinical condition.

Hyperlipidemia

This medicine should be used with caution in patients suffering from hyperlipidemia due to the increased risk of worsening of the patient's condition. Close monitoring of cholesterol levels, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Hyperthyroidism

This medicine should be administered with caution in patients suffering from hyperthyroidism since it may mask some of the patient's symptoms. Report any unusual symptoms to the doctor immediately. Close monitoring of thyroid hormone levels is recommended for such patient. Replacement with a suitable alternative may be required based on the clinical condition.

Myasthenia Gravis

This medicine should be used with caution in patients suffering from myasthenia gravis since it may worsen the patient's condition. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.

Pheochromocytoma

This medicine should be used with caution in patients suffering from pheochromocytoma since it may worsen the patient's condition. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
It is advised to avoid potassium containing foods and supplements while taking this medicine due to the increased risk of weakness, confusion, irregular heartbeat, etc. Report any unusual symptoms to the doctor immediately. Your dietitian/doctor may suggest appropriate changes in your diet based on your clinical condition.
Lab interactions
Information not available.
Take this medicine as advised by your doctor. It can be taken with or without food. Do not take in larger amounts than prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Valsartan relaxes the blood vessels and promotes the smooth flow of blood. Nebivolol relaxes the blood vessels and reduces the heart rate, promoting a smooth flow of the blood. Their combination is thus effective in reducing the blood pressure.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Miscellaneous antihypertensive combinations

Schedule

Schedule H

[Internet]. 2017 [cited 16 October 2017]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206302s000lbl.pdf

[Internet]. 2017 [cited 25 July 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/30901

Valsartan: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 25 July 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a697015.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 20 Nov 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.